Suppr超能文献

原发性肝淋巴瘤的 MRI 特征。

MRI features of primary hepatic lymphoma.

机构信息

Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.

Medical Physics Department, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.

出版信息

Abdom Radiol (NY). 2018 Sep;43(9):2277-2287. doi: 10.1007/s00261-018-1476-5.

Abstract

PURPOSE

Our retrospective study sought to describe the spectrum of magnetic resonance imaging (MRI) features of primary hepatic lymphoma (PHL) by analyzing its morphological aspects, signal intensity before and after contrast agent (CA) administration, and diffusion-weighted imaging (DwI) with the apparent diffusion coefficient (ADC) values.

METHODS

A retrospective analysis was conducted on 25 patients with pathologically proven PHL who underwent MRI between January 2011 and December 2016. For the evaluation of the ADC, we used a control group of 87 patients (22 with hepatocellular carcinoma, 15 with cholangiocellular carcinoma, 23 with liver metastasis, 22 with focal nodular hyperplasia, and 5 with adenoma). Two radiologists evaluated the morphological features, the signal intensity before and after CA administration, and the DwI. The sensitivity and specificity of the ADC values in distinguishing the PHL lesions from other hepatic lesions were calculated by analyzing the receiver operating characteristic (ROC) curves.

RESULTS

Twenty-one patients had non-Hodgkin's lymphoma (18 had diffuse large B-cell lymphoma and three had mucosa-associated lymphoid tissue) and four had Hodgkin's lymphoma (nodular sclerosis). The PHL had a variable morphologic distribution (17 focal mass and eight multiple nodules) and mainly an insinuative growth (24/25). Usually, PHL was usually hypointense on the T1-weighted images (23/25) and hyperintense on the T2-weighted images (21/25); non-specific dynamic enhancement was found after CA administration, but in the hepatobiliary phase, PHL is mainly hypointense (92%). All PHLs showed a signal restriction in the DwI. The sensitivity and specificity in the differential diagnosis between PHL and the other malignant lesions were respectively 81.7% and 100%, with applying an ADC cut-off value of 0.918 × 10 mm/s.

CONCLUSION

Although PHL is a rare disease and biopsy is still required, an MRI could be indicative. In our series, PHL showed an insinuative growth, hypointense signal in the hepatobiliary phase, signal restriction in the DwI, and an ADC value lower than that of the other hepatic lesions analyzed.

摘要

目的

通过分析原发性肝淋巴瘤(PHL)的形态学表现、对比剂(CA)给药前后的信号强度以及表观扩散系数(ADC)值的弥散加权成像(DwI),我们旨在描述其磁共振成像(MRI)特征的范围。

方法

回顾性分析了 2011 年 1 月至 2016 年 12 月期间经 MRI 检查并经病理证实的 25 例 PHL 患者。为了评估 ADC,我们使用了 87 例患者的对照组(22 例肝细胞癌、15 例胆管细胞癌、23 例肝转移、22 例局灶性结节性增生和 5 例腺瘤)。两位放射科医生评估了形态特征、CA 给药前后的信号强度以及 DwI。通过分析受试者工作特征(ROC)曲线,计算 ADC 值在鉴别 PHL 病变与其他肝脏病变方面的敏感性和特异性。

结果

21 例患者患有非霍奇金淋巴瘤(18 例弥漫性大 B 细胞淋巴瘤,3 例黏膜相关淋巴组织),4 例患有霍奇金淋巴瘤(结节性硬化)。PHL 的形态分布具有变异性(17 例为局灶性肿块,8 例为多发性结节),主要为浸润性生长(24/25)。通常,PHL 在 T1 加权图像上呈低信号(23/25),在 T2 加权图像上呈高信号(21/25);CA 给药后发现非特异性动态增强,但在肝胆期,PHL 主要呈低信号(92%)。所有 PHL 在 DwI 上均显示信号受限。PHL 与其他恶性病变鉴别诊断的敏感性和特异性分别为 81.7%和 100%,ADC 截断值为 0.918×10mm/s。

结论

尽管 PHL 是一种罕见疾病,仍需要进行活检,但 MRI 可以提供线索。在我们的系列中,PHL 表现为浸润性生长、肝胆期低信号、DwI 信号受限以及低于我们分析的其他肝脏病变的 ADC 值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验